Skip to main content
. Author manuscript; available in PMC: 2021 Aug 1.
Published in final edited form as: Contemp Clin Trials. 2020 Jun 21;95:106067. doi: 10.1016/j.cct.2020.106067

Table 1.

Study Measures (months)

Item 0 12 24 36

Blood1

 Fasting glucose and insulin x x x x
 HbA1c x x x x
 Fasting lipid panel x x x x
 Liver and kidney panels x x x x
 Vitamin B12 x x
 Plasma Metformin2 x x

Urine1

 Microalbuminuria x x x x

Anthropometric and clinic measures

 Blood pressure x x x x
 Weight, height, and BMI x x x x
 Waist and hip circumferences x x x x

Interviews/Questionnaires

 Adherence to metformin Rx3 x x x x
 Food frequency x x x x
 Food insecurity x x x x
 Physical activity x x x x

Contact and sociodemographics

 Tobacco and alcohol use x x x x
 History of hypertension, obesity, hyperlipidemia, heart disease (self-report and chart review) x x x x
 Family history of diabetes in 1st degree relatives x x x x
 Current medication use (self-report and chart review) x x x x
 Lifestyle changes self-efficacy x x x x
 Quality of life x x x x
1

Biomarkers are analyzed centrally at the Salvador Zubiran National Institute of Medical Sciences and Nutrition

2

ln LS+M arm, all 12- and −24-month samples will be included; a 10% random sample from LSO arm will also be included.

3

Applies to patients on LS+M arm only; in addition, adherence is measured monthly.